|
|
News Breaks | | | | November 21, 2012 | | 11:32 EDT |  | HTWR, THOR | HeartWare falls, Thoratec rallies after Wells Fargo flips ratings
Heart pump maker HeartWare (HTWR) is sinking and its competitor, Thoratec (THOR), is climbing after Wells Fargo wrote that the high rate of strokes among patients who have used Heartware's HVAD pump is worrisome. In a trial of Heartware's HVAD pump, which is designed to draw blood from the left ventricle and propel it through an outflow graft connected to the patient's ascending aorta, 11.8% of patients who used the device developed strokes, versus just 4.3% of patients who used a similar product made by Thoratec, Wells Fargo wrote in a note to investors, citing interim data. As a result, HeartWare has placed a warning about strokes on the instructions for its HVAD pump. Wells Fargo believes that this warning may curtail sales of HeartWare's device in the U.S., and the firm downgraded the company's stock to Market Perform from Outperform in a note to investors today. Wells Fargo also upgraded Thoratec to Outperform from Market Perform, as it expects the company to benefit from reduced demand for HeartWare's solution. Moreover, Wells predicts that HeartWare will report lower than expected 2013 revenue, while Thoratec is likely to beat 2013 revenue expectations. The firm also believes there is now a greater chance that HeartWare's device will not be approved as a destination therapy. In late morning trading, HeartWare fell $4.18, or 4.67%, to $85.36, while Thoratec climbed $1.91, or 5.46%, to $36.91. | |
|
News For HTWR;THOR From The Last 14 Days Check below for free stories on HTWR;THOR the last two weeks. |
|
|
| May 20, 2013 | | 10:11 EDT |  | THOR | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Artisan Partners (APAM) downgraded to Market Perform from Outperform at Keefe Bruyette... Bank of America (BAC) downgraded to Market Perform from Outperform at Keefe Bruyette... Bed Bath & Beyond (BBBY) downgraded to Hold from Buy at Jefferies... BlackRock (BLK) downgraded to Market Perform from Outperform at Keefe Bruyette... Cavium (CAVM) downgraded to Market Perform from Outperform at JMP Securities... Charles Schwab (SCHW) downgraded to Underperform from Market Perform at Keefe Bruyette... Dunkin' Brands (DNKN) downgraded to Neutral from Buy at Longbow... Equifax (EFX) downgraded to Neutral from Buy at Goldman... Leap Wireless (LEAP) downgraded to Sell from Hold at Deutsche Bank... Lowe's (LOW) downgraded to Perform from Outperform at Oppenheimer... MicroStrategy (MSTR) downgraded to Market Perform from Outperform at JMP Securities... NetApp (NTAP) downgraded to Underperform from Neutral at RW Baird... NeuStar (NSR) downgraded to Neutral from Buy at Goldman... Red Hat (RHT) downgraded to Market Perform from Outperform at BMO Capital... Ruby Tuesday (RT) downgraded to Market Perform from Outperform at Wells Fargo... Synovus (SNV) downgraded to Sell from Neutral at Goldman... TD Ameritrade (AMTD) downgraded to Underperform from Market Perform at Keefe Bruyette... Thoratec (THOR) downgraded to Neutral from Buy at Goldman... CF Industries (CF) downgraded to Hold from Buy at Miller Tabak... Children's Place (PLCE) downgraded at Susquehanna... CarMax (KMX) downgraded to Market Perform from Outperform at William Blair... SanDisk (SNDK) downgraded to Neutral from Buy at Nomura... Red Hat (RHT) downgraded at BMO Capital... Rex Energy (REXX) downgraded to Hold from Buy at Stifel... Range Resources (RRC) downgraded to Hold from Buy at Stifel... Kansas City Southern (KSU) downgraded to Sell from Hold at Stifel... Capella Education (CPLA) downgraded to Hold from Buy at Stifel. | | | 06:06 EDT | | THOR | Thoratec downgraded to Neutral from Buy at Goldman
 Subscribe for More Information | | | May 17, 2013 | | 08:04 EDT | | THOR | Thoratec announces FDA approval of HeartMate II Pocket Controller
Thoratec announced that it has received approval from the FDA to market the HeartMate II Pocket Controller, the small, smart, safe face of the HeartMate II LVAD System. | | | May 13, 2013 | | 10:09 EDT | | THOR | On The Fly: Analyst Downgrade Summary
Subscribe for More Information | | | 07:31 EDT | | THOR | Thoratec downgraded to Neutral from Buy at Lazard Capital
Subscribe for More Information | |
|
|
|
|
|
|
